Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Interventional
×
necitumumab
×
Clear all
Filters
3
NCT00981058
2025-06-18
SQUIRE
Eli Lilly and Company
Phase 3
Completed
1,093 enrolled
24 charts
NCT00982111
2022-01-11
INSPIRE
Eli Lilly and Company
Phase 3
Completed
633 enrolled
25 charts